PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression

SIMPLE SUMMARY: Despite the impressive clinical impact of programmed death-ligand 1 (PD-L1)/programmed cell death-1 (PD-1) blockade in solid tumors, the use of these checkpoint inhibitors in multiple myeloma (MM) still remains debated with unsatisfying clinically meaningful results. In this review w...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Federica, Marchica, Valentina, Storti, Paola, Malavasi, Fabio, Giuliani, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825118/
https://www.ncbi.nlm.nih.gov/pubmed/33418913
http://dx.doi.org/10.3390/cancers13020164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825118/
https://www.ncbi.nlm.nih.gov/pubmed/33418913
http://dx.doi.org/10.3390/cancers13020164

Ejemplares similares